(Q38186147)

30 August 2017

1 reference

title

Regulation of natural killer activity (English)

1 reference

30 August 2017

J R Ortaldo

1

1 reference

30 August 2017

1 January 1987

1 reference

Cancer and Metastasis Reviews

30 August 2017

1 reference

30 August 2017

6

1 reference

30 August 2017

637-651

1 reference

30 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00047471

30 August 2017

0 references

cites work

Regulation of human natural killing. I. The role of monocytes, interferon, and prostaglandins

1 reference

12 December 2020

Characteristics of human large granular lymphocytes and relationship to natural killer and K cells

1 reference

12 December 2020

Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells

1 reference

12 December 2020

Natural killer cells. In vitro and in vivo

1 reference

12 December 2020

Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells

1 reference

12 December 2020

Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies

1 reference

12 December 2020

Natural killer cells: their roles in defenses against disease

1 reference

12 December 2020

Interleukin 2 enhances natural killer cell activity through induction of gamma interferon.

1 reference

12 December 2020

Involvement of the 2'-5' A pathway in the augmentation of natural killer activity

1 reference

12 December 2020

Interferon and prostaglandins: effects on human natural and lectin-induced cytotoxicity

1 reference

12 December 2020

Lymphokine-activated killer cells. Analysis of progenitors and effectors

1 reference

12 December 2020

Interleukin 2 high-affinity receptor expression requires two distinct binding proteins

1 reference

12 December 2020

Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells

1 reference

12 December 2020

Mechanism of cytotoxicity by natural killer (NK) cells

1 reference

12 December 2020

Clonal expansion of human B73.1-positive natural killer cells or large granular lymphocytes exerting strong antibody-dependent and -independent cytotoxicity and occasionally lectin-dependent cytotoxicity.

1 reference

12 December 2020

Studies of murine large granular lymphocytes. I. Identification as effector cells in NK and K cytotoxicities

1 reference

12 December 2020

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation

1 reference

12 December 2020

Natural killer cells and interferon.

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 reference

12 December 2020

Effects of metabolic inhibitors on spontaneous and interferon-boosted human natural killer cell activity

1 reference

12 December 2020

Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.

1 reference

12 December 2020

Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses

1 reference

12 December 2020

The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes

1 reference

12 December 2020

Natural Cell-Mediated Immunity

1 reference

12 December 2020

The dual effect of prostaglandin (PGE2) and ethanol on the natural killer cytolytic process: effector activation and NK-cell-target cell conjugate lytic inhibition

1 reference

12 December 2020

Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen).

1 reference

12 December 2020

The use of intraperitoneal chemotherapy in the treatment of ovarian cancer

1 reference

12 December 2020

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis

1 reference

12 December 2020

The beige mutation in the mouse selectively impairs natural killer cell function

1 reference

12 December 2020

Effects of recombinant and hybrid recombinant human leukocyte interferons on cytotoxic activity of natural killer cells

1 reference

12 December 2020

Phytohemagglutinin-induced proliferation and cytolytic activity in T3+ but not in T3- cloned T lymphocytes requires the involvement of the T3 antigen for signal transmission

1 reference

12 December 2020

Adoptive cellular immunotherapy of human ovarian carcinoma xenografts in nude mice.

1 reference

12 December 2020

Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects

1 reference

12 December 2020

Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation

1 reference

12 December 2020

Characteristics of human NK clones: target specificity and phenotype

1 reference

12 December 2020

Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver

1 reference

12 December 2020

Regulation of human large granular lymphocyte and T cell growth and function by recombinant interleukin 2: induction of interleukin 2 receptor and promotion of growth of cells with enhanced cytotoxicity

1 reference

12 December 2020

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis

1 reference

12 December 2020

Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.

1 reference

12 December 2020

Augmentation of mouse natural killer cell activity by interferon and interferon inducers

1 reference

12 December 2020

Natural cytotoxic cells against solid tumors in mice: a comparison with natural killer cells.

1 reference

12 December 2020

Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells

1 reference

12 December 2020

The role of interleukin 1 (IL 1) in tumor-NK cell interactions: correction of defective NK cell activity in cancer patients by treating target cells with IL 1.

1 reference

12 December 2020

Do Natural Killer Cells Engage in Regulated Reactions Against Self to Ensure Homeostasis?

1 reference

12 December 2020

Inhibition of murine natural killer cell activity by prostaglandins

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00047471

1 reference

PubMed ID

2450688

Dimensions Publication ID

30 August 2017

0 references

1 reference

PubMed ID

2450688